Ingalls & Snyder LLC Biogen Inc. Transaction History

Ingalls & Snyder LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $165,700 - $212,949	-740 Closed	0 $0
Q3 2021 Oct 27, 2021	BUY	$282.99 - $369.05 $25,469 - $33,214	90 Added 13.85%	740 $209,000
Q2 2021 Aug 03, 2021	SELL	$259.0 - $414.71 $18,130 - $29,029	-70 Reduced 9.72%	650 $225,000
Q1 2021 Apr 21, 2021	BUY	$242.95 - $284.63 $174,924 - $204,933	720 New	720 $201,000
Q1 2020 Apr 22, 2020	SELL	$268.85 - $341.04 $197,604 - $250,664	-735 Closed	0 $0
Q4 2019 Jan 15, 2020	SELL	$220.06 - $304.07 $30,808 - $42,569	-140 Reduced 16.0%	735 $218,000
Q3 2019 Oct 16, 2019	SELL	$217.44 - $243.88 $1.26 Million - $1.41 Million	-5,789 Reduced 86.87%	875 $204,000
Q2 2019 Jul 11, 2019	SELL	$219.29 - $241.72 $1.18 Million - $1.3 Million	-5,381 Reduced 44.67%	6,664 $1.56 Million
Q1 2019 Apr 11, 2019	BUY	$216.71 - $338.96 $998,599 - $1.56 Million	4,608 Added 61.96%	12,045 $2.85 Million
Q4 2018 Jan 24, 2019	SELL	$278.5 - $352.75 $84,385 - $106,883	-303 Reduced 3.91%	7,437 $2.24 Million
Q3 2018 Oct 24, 2018	SELL	$293.51 - $383.83 $17,317 - $22,645	-59 Reduced 0.76%	7,740 $2.74 Million
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $100,432 - $119,694	-390 Reduced 4.76%	7,799 $2.26 Million
Q1 2018 Apr 17, 2018	BUY	$260.13 - $367.91 $395,657 - $559,591	1,521 Added 22.81%	8,189 $2.24 Million
Q4 2017 Jan 19, 2018	BUY	$307.64 - $344.58 $151,051 - $169,188	491 Added 7.95%	6,668 $2.12 Million
Q3 2017 Oct 20, 2017	BUY	$281.15 - $329.69 $1.74 Million - $2.04 Million	6,177	6,177 $1.93 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.